Menu Search
Equities

Addus Homecare Corp

ADUS:NSQ

Addus Homecare Corp

Actions
Health CareHealth Care Providers
  • Price (USD)127.58
  • Today's Change-1.50 / -1.16%
  • Shares traded140.60k
  • 1 Year change+53.66%
  • Beta1.0294
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Addus Homecare Corp grew revenues 11.31% from 951.12m to 1.06bn while net income improved 35.83% from 46.03m to 62.52m.
Gross margin32.15%
Net profit margin6.50%
Operating margin9.15%
Return on assets6.73%
Return on equity9.03%
Return on investment7.79%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Addus Homecare Corp fell by 15.17m. However, the company earned 112.25m from its operations for a Cash Flow Margin of 10.60%. In addition the company used 119.24m on investing activities and also paid 8.18m in financing cash flows.
Cash flow per share5.20
Price/Cash flow per share26.40
Book value per share52.26
Tangible book value per share10.89
More ▼

Balance sheet in USDView more

Addus Homecare Corp uses little or no debt in its capital structure.
Current ratio2.11
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 34.75%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)23.82
EPS (TTM) vs
TTM 1 year ago		23.26
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.